Pricing Log in Create free account
Friday 6 November 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024.

Revenue
+19.2%
EPS
+64.1%
Free cash flow
−29.8%
Total debt
−5.19%

Quarter to September 2026, against a year earlier

145.46 10.66 −6.83%
Market cap
$10.8B
P/E
25.2×
Fwd P/E
24.4×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Insulet Corporation (PODD) SEC filings, changes and red flags

Red flags

  • Receivables outpacing revenue

    Receivables grew 49.1% while revenue grew 19.2% year over year

    10-Q filed · The filing · sec.gov

  • Material weakness

    Insulet Corporation’s 10-Q reports a material weakness in internal control over financial reporting

    Management believes that these actions will remediate the material weakness; however, the material weakness will not be considered remediated until management has concluded that these controls are operating effectively.

    10-Q filed · The filing · sec.gov

  • Officer departure

    Insulet Corporation reported the departure of an officer or director

    8-K filed · The filing · sec.gov

  • Auditor change

    Insulet Corporation reported a change of its independent auditor

    8-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 9 added · 4 removed · 51 modified
P2I1A: no material changes, the filing says 		Receivables outpacing revenue
8-K Nov 4, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 21, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Sep 14, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Sep 3, 2026 5.02 Departure or appointment of directors or officers
10-Q Jun 30, 2026 P1I2: 6 added · 2 removed · 28 modified
P2I1A: no comparison — incorporated by reference
8-K Aug 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 24, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 26, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 20, 2026 5.03 Amendments to the articles or bylaws; change in fiscal year; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026 P1I2: 18 added · 27 removed · 36 modified
P2I1A: no comparison — incorporated by reference
8-K May 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 29, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 12, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Feb 27, 2026 5.02 Departure or appointment of directors or officers
8-K/A Dec 15, 2025 4.01 Change in the certifying accountant; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 8 added · 25 removed · 56 modified
1A: 10 added · 47 removed · 75 modified
7: 22 added · 22 removed · 42 modified
8-K Feb 18, 2026 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 29, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Dec 15, 2025 4.01 Change in the certifying accountant; 9.01 Financial statements and exhibits Auditor change
8-K Dec 11, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 P1I2: 7 added · 8 removed · 25 modified
P2I1A: no comparison — incorporated by reference
8-K Nov 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 21, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 11, 2025 5.02 Departure or appointment of directors or officers; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025 P1I2: 14 added · 4 removed · 30 modified
P2I1A: no comparison — incorporated by reference
8-K Aug 7, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025 P1I2: no comparison — the earlier filing's text is no longer kept
P2I1A: no comparison — incorporated by reference
8-K May 8, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024 1: no comparison — no earlier filing on file
1A: no comparison — no earlier filing on file
7: no comparison — no earlier filing on file
8-K Feb 20, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024 Material weakness
8-K Nov 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 8, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 26, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 9, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 22, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.